Skip to content

Clinical trials

Sepsis trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sepsis Country / region: New Zealand Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20082
20122
20141
20151
20171
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
The George Institute2
Asahi Kasei Pharma America Corporation1
Australian and New Zealand Intensive Care Research Centre1
Belinda Howe1
GlaxoSmithKline1
La Jolla Pharmaceutical Company1
Sunnybrook Health Sciences Centre1
Takeda1
The University of Queensland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sepsis12
Shock, Septic6
Critical Illness2
Bacteremia1
Hemostatic Disorders1
Respiratory Insufficiency1
Systemic Inflammatory Response Syndrome1
Vasoplegia1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.